← Back to all trials
Withdrawn
NCT04800107
Effect of Highly Bioavailable Curcumin on Subjective Tinnitus
Conditions: Tinnitus, Subjective
Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: No
Phase: NA
Sponsor: Henry Ford Health System
Location: Michigan Ear Institute Farmington Hills Michigan
Summary
This study will assess the effectiveness of highly bioavailable curcumin in suppressing subjective tinnitus based on pre- and post-treatment evaluations using the validated Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI) surveys.
Eligibility Criteria
Inclusion Criteria:
* Adults with subjective tinnitus due to sensorineural hearing loss as determined by routine audiogram.
Exclusion Criteria:
* Adults with subjective tinnitus due to another cause
* Sensitivity or allergy to test compounds
* Use of other off-label medications, substances, treatments specifically for tinnitus mitigation (e.g., anti-depressant/anxiety medications, GABA-inhibitors, psychiatric-based interventions/counseling)
* Pregnancy
* Patients taking anticoagulants to minimize risk of drug-drug interactions.
Source: ClinicalTrials.gov (NCT04800107). StuddyBuddy aggregates publicly available trial information.